CEACAM1 and pachyonychia congenita: CEACAM-1 [68, 69], CEACAM-6 [70–72], CD133 [73–75], S100A4 [76–80], and midkine [81] have been shown to be biomarkers that are also expressed in PC and are significantly associated with invasion and metastasis in PC and PC prognosis.